Matches in Wikidata for { <http://www.wikidata.org/entity/Q61835374> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q61835374 description "article" @default.
- Q61835374 description "wetenschappelijk artikel" @default.
- Q61835374 description "наукова стаття, опублікована в грудні 2011" @default.
- Q61835374 name "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 name "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 type Item @default.
- Q61835374 label "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 label "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 prefLabel "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 prefLabel "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemo" @default.
- Q61835374 P1433 Q61835374-62775654-9963-48A1-88E0-0AB7C8F15D2F @default.
- Q61835374 P1476 Q61835374-C55FAD72-761A-4FCC-BAD9-0ADD7B4AAB19 @default.
- Q61835374 P2093 Q61835374-364D78F1-DAF9-421F-A7D2-51E7A5389171 @default.
- Q61835374 P2093 Q61835374-373D9C16-2FBA-4311-AF33-CDDFCB697198 @default.
- Q61835374 P2093 Q61835374-3C5CAC2A-5EAE-41C5-BA07-896AF003725D @default.
- Q61835374 P2093 Q61835374-4F00B0ED-DE17-42CF-8DB0-B69C94A95C20 @default.
- Q61835374 P2093 Q61835374-7FA2682A-2875-483E-B14B-B3D2090D329A @default.
- Q61835374 P2093 Q61835374-8C79FFAA-C2E1-4FEC-BF95-9FD72DF1CB12 @default.
- Q61835374 P2093 Q61835374-904A18CB-8E0C-478D-A0CE-BE4209A7BDE8 @default.
- Q61835374 P2093 Q61835374-932A7AB0-D02A-45A5-BD11-F34490B4EF4E @default.
- Q61835374 P2093 Q61835374-A5D37C03-7244-4483-9213-DFEB1E43068A @default.
- Q61835374 P2093 Q61835374-A6853009-3138-4856-8AC9-6C07FD1D678C @default.
- Q61835374 P2093 Q61835374-ADDD449B-4C20-4FEB-B990-D37C9A3B6679 @default.
- Q61835374 P2093 Q61835374-CFEFC35C-AA24-42BA-90D0-882499A35939 @default.
- Q61835374 P2093 Q61835374-EC514565-4743-4177-96D8-76DE1BBBC98D @default.
- Q61835374 P304 Q61835374-E5C82509-7892-47D8-8A2B-A44DF1707243 @default.
- Q61835374 P31 Q61835374-77B9EBA4-6B35-4E3D-A290-E0E36DBF043E @default.
- Q61835374 P356 Q61835374-8DAC8375-D798-4189-B9D1-9AC7BDE71A12 @default.
- Q61835374 P433 Q61835374-638E10A1-288F-44BF-8FE4-D16689292769 @default.
- Q61835374 P478 Q61835374-53BBA5E8-CE28-4CCB-9FE0-54F158767A85 @default.
- Q61835374 P50 Q61835374-C8FEC051-5150-42FA-8E45-F50814210FF5 @default.
- Q61835374 P577 Q61835374-565D3E3E-CD0F-4B55-957F-5280C1285E39 @default.
- Q61835374 P698 Q61835374-EC24A10D-2310-4454-8028-C5BBC21172C5 @default.
- Q61835374 P921 Q61835374-260298E9-E6F1-4C3C-9809-D341C3856DFC @default.
- Q61835374 P921 Q61835374-A2BC940E-C178-4550-88A9-2B2B32481A4C @default.
- Q61835374 P356 J.ACVD.2011.09.001 @default.
- Q61835374 P698 22152517 @default.
- Q61835374 P1433 Q2366616 @default.
- Q61835374 P1476 "Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis" @default.
- Q61835374 P2093 "Anne Godier" @default.
- Q61835374 P2093 "Annick Steib" @default.
- Q61835374 P2093 "Charles M Samama" @default.
- Q61835374 P2093 "French Study Group on Thrombosis and Haemostasis" @default.
- Q61835374 P2093 "Gilles Pernod" @default.
- Q61835374 P2093 "Isabelle Gouin-Thibault" @default.
- Q61835374 P2093 "Juan V Llau" @default.
- Q61835374 P2093 "Nadia Rosencher" @default.
- Q61835374 P2093 "Philippe Van der Linden" @default.
- Q61835374 P2093 "Pierre Albaladejo" @default.
- Q61835374 P2093 "Pierre Sié" @default.
- Q61835374 P2093 "Thomas Lecompte" @default.
- Q61835374 P2093 "Working Group on Perioperative Haemostasis" @default.
- Q61835374 P304 "669-676" @default.
- Q61835374 P31 Q13442814 @default.
- Q61835374 P356 "10.1016/J.ACVD.2011.09.001" @default.
- Q61835374 P433 "12" @default.
- Q61835374 P478 "104" @default.
- Q61835374 P50 Q56679064 @default.
- Q61835374 P577 "2011-10-29T00:00:00Z" @default.
- Q61835374 P698 "22152517" @default.
- Q61835374 P921 Q261327 @default.
- Q61835374 P921 Q63279445 @default.